Kura Oncology, Inc. (KURA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$13.25+0.76%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · KURA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 77.2 | 67.5 | 53.9 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | 120.0 | — | 50.6 | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 259.5 | 251.1 | 170.0 | 115.2 | 92.8 | 84.7 | 60.4 | 47.8 | — | — | — | — | — | — | — | — |
| Operating Income | (318.1) | (303.6) | (193.2) | (165.8) | (139.9) | — | — | — | — | — | — | — | (0.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 1.5 | 1.6 | 1.5 | 0.2 | 0.4 | 0.6 | 0.6 | 1.0 | 0.9 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | 0.8 | 0.5 | 0.1 | — | — | — | — |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | 0.1 | — | (0.1) | — | — | — | — |
| Other Non-Operating Income / Expenses | 21.4 | 25.3 | 21.2 | 13.2 | 4.0 | 0.8 | 2.3 | 4.3 | 2.4 | 0.6 | 0.8 | 1.2 | — | — | — | — |
| EBT, Incl. Unusual Items | (296.7) | (278.4) | (172.0) | (152.6) | (135.8) | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.3 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (296.8) | (278.7) | (174.0) | (152.6) | (135.8) | (130.5) | (89.6) | (63.1) | (60.4) | (35.4) | (27.6) | (22.6) | (0.0) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (3.34) | (3.18) | (2.02) | (2.08) | (2.03) | (1.97) | (1.69) | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (3.34) | (3.18) | (2.02) | (2.08) | (2.03) | (1.97) | (1.69) | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.87 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 88.9 | 87.7 | 86.2 | 73.2 | 67.0 | 66.4 | 53.1 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 88.9 | 87.7 | 86.2 | 73.2 | 67.0 | 66.4 | 53.1 | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBIT | (318.1) | (303.6) | (193.2) | (165.8) | (139.9) | — | — | — | — | — | — | — | (0.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.